Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHAINARONG LIMVARAPUSS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1053341784
CMS profile
47890
Location
VALLEJO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$8,228.90

234 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,964.15 230
Consulting Fee $3,133.00 2
Education $131.75 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
BeiGene USA, Inc. $2,004.56 8
Regeneron Healthcare Solutions, Inc. $1,211.86 2
PFIZER INC. $370.35 20
E.R. Squibb & Sons, L.L.C. $333.71 23
Janssen Biotech, Inc. $275.83 10
Amgen Inc. $260.44 13
AstraZeneca Pharmaceuticals LP $196.21 9
Takeda Pharmaceuticals U.S.A., Inc. $194.72 10
Merck Sharp & Dohme LLC $190.71 8
Genentech USA, Inc. $189.51 8
Novartis Pharmaceuticals Corporation $184.23 9
Kite Pharma, Inc. $184.22 5
Seagen Inc. $184.11 9
Celgene Corporation $181.56 11
Karyopharm Therapeutics Inc. $176.83 4
US Oncology Corporate, Inc. $173.70 3
Eisai Inc. $163.07 8
GlaxoSmithKline, LLC. $142.10 8
Mirati Therapeutics, Inc. $139.40 6
Gilead Sciences, Inc. $139.27 6
GENZYME CORPORATION $112.14 4
SOBI, INC $106.95 4
Stemline Therapeutics Inc. $98.60 4
Apellis Pharmaceuticals, Inc. $95.27 4
Lilly USA, LLC $89.02 3
ARRAY BIOPHARMA INC $84.28 4
Incyte Corporation $83.98 4
Daiichi Sankyo Inc. $70.26 3
PharmaEssentia USA Corporation $57.48 2
Pharmacyclics LLC, An AbbVie Company $57.30 2
Astellas Pharma US Inc $55.86 3
Blueprint Medicines Corporation $48.50 1
Dendreon Pharmaceuticals LLC $40.31 1
JAZZ PHARMACEUTICALS INC. $33.55 1
Exelixis Inc. $33.14 1
Sumitomo Pharma America, Inc. $29.17 1
Rigel Pharmaceuticals, Inc. $27.73 1
Alexion Pharmaceuticals, Inc. $27.66 1
AVEO Pharmaceuticals, Inc. $24.70 1
ADC Therapeutics America, Inc. $24.43 1
SERVIER PHARMACEUTICALS LLC $21.31 1
Alnylam Pharmaceuticals Inc. $21.17 1
Bayer Healthcare Pharmaceuticals Inc. $21.07 1
Organon LLC $20.42 1
Amneal Pharmaceuticals LLC $16.72 1
Myriad Genetic Laboratories, Inc. $14.31 1
Foundation Medicine, Inc. $13.30 1
Emmaus Medical, Inc. $3.88 1

Page 5 of 5; records 201–234 of 234 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHAINARONG LIMVARAPUSS

NPI 1053341784 · CMS profile ID 47890

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

VALLEJO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 5; records 201–234 of 234 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053341784?year=2023&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–234 of 234 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053341784?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–234 of 234 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053341784?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 5; records 201–234 of 234 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1053341784?year=2023&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

234 matching records · $8,228.90 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 234 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–234 of 234.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $28.9802/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049668305 CMS
E.R. Squibb & Sons, L.L.C. $114.6202/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015948395 CMS
Regeneron Healthcare Solutions, Inc. $1,208.0002/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999275383 CMS
Seagen Inc. $24.4002/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995681267 CMS
Amgen Inc. $16.7502/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019854685 CMS
Seagen Inc. $29.2202/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995681293 CMS
Novartis Pharmaceuticals Corporation $34.6302/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992104077 CMS
Dendreon Pharmaceuticals LLC $40.3102/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060287495 CMS
Janssen Biotech, Inc. $12.6402/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988052189 CMS
Apellis Pharmaceuticals, Inc. $18.0602/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056376075 CMS
AstraZeneca Pharmaceuticals LP $23.7302/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014839025 CMS
PFIZER INC. $2.3302/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049541043 CMS
AstraZeneca Pharmaceuticals LP $12.4602/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015014857 CMS
Amgen Inc. $17.8401/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020551203 CMS
Lilly USA, LLC $30.0001/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031298499 CMS
Karyopharm Therapeutics Inc. $32.4201/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056898337 CMS
Merck Sharp & Dohme LLC $13.4501/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048583909 CMS
SOBI, INC $29.7801/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038084355 CMS
Amgen Inc. $32.6101/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019854689 CMS
Apellis Pharmaceuticals, Inc. $26.2501/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056349059 CMS
Genentech USA, Inc. $25.2401/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040323901 CMS
PFIZER INC. $22.5001/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049115945 CMS
Rigel Pharmaceuticals, Inc. $27.7301/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033387757 CMS
Seagen Inc. $22.8001/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995681261 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.7301/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055457283 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.7401/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055457289 CMS
Amgen Inc. $13.2701/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020551201 CMS
Celgene Corporation $23.7501/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015948351 CMS
GENZYME CORPORATION $20.6301/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049847323 CMS
GENZYME CORPORATION $36.5401/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049847331 CMS
JAZZ PHARMACEUTICALS INC. $33.5501/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058397771 CMS
Mirati Therapeutics, Inc. $18.7501/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057996305 CMS
Emmaus Medical, Inc. $3.8801/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014084781 CMS
Novartis Pharmaceuticals Corporation $22.5901/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992104053 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,465.16 244
PY2020 $7,138.60 71
PY2021 $4,635.30 233
PY2022 $14,191.47 276
PY2023 $8,228.90 234
PY2024 $5,772.17 191
PY2025 $4,852.26 202

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $5,100.00 3
PY2022 Principal investigator $16,500.00 3
PY2021 Principal investigator $14,677.00 11
PY2020 Principal investigator $6,120.00 4
PY2019 Principal investigator $2,760.00 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 MorphoSys AG $1,500.00 12/01/2023 Non-covered Recipient Entity
Solano Hematology Oncology
realMIND: A Multicenter, Observational Study to Characterize the Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in US Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma With a Focus on Racial and Ethnic Minority Patients No dispute reported 06/30/2026 1060334937
Principal investigator 1 MorphoSys AG $600.00 06/14/2023 Non-covered Recipient Entity
Solano Hematology Oncology
realMIND: A Multicenter, Observational Study to Characterize the Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in US Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma With a Focus on Racial and Ethnic Minority Patients No dispute reported 06/30/2026 1060334935
Principal investigator 1 PFIZER INC. $3,000.00 01/05/2023 Non-covered Recipient Entity
Solano Hematology Oncology
POLARIS PALBOCICLIB IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER A PROSPECTIVE MULTICENTER NONINTERVENTIONAL STUDY No dispute reported 06/30/2026 1046547031